Terumo Aortic announced enrollment of the first patient in the RapidLink pivotal trial, which will evaluate the safety and ...

Enrollment completed across 18 clinical sites with 40+ investigators in the US, Canada, and New Zealand If the GPX ...

Recently, security researchers Prompt Armor published a new report, stating that IBM’s coding agent, which is currently in ...

Partnership expands access to clinically proven esophageal protection for atrial fibrillation ablation across federal ...

Allotex Inc., a commercial-stage ophthalmic company with active European market adoption, today announced that the U.S. Food and Drug Administration (FDA) has conditionally approved its ...

That's apparently the case with Bob. IBM's documentation, the PromptArmor Threat Intelligence Team explained in a writeup provided to The Register, includes a warning that setting high-risk commands ...

The filing comes about a month after competitor Medtronic won FDA approval for the Hugo robotic-assisted surgery system.

Fluidx Medical Technology, Inc. announced the completion of patient enrollment in the investigational device exemption (IDE) piv ...

Johnson & Johnson today announced that the company has submitted the OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration (FDA) in an application for De Novo classification.

Johnson & Johnson MedTech announced today that it submitted its Ottava surgical robotic system to the FDA for de novo ...

Keeper Security, the leading provider of zero-trust and zero-knowledge cybersecurity software protecting passwords and passkeys, infrastructure secrets, remote connections and endpoints, today ...

Abbott’s Volt pulsed field ablation system — for the treatment of atrial fibrillation. The Volt system delivers high-energy electrical pulses to targeted areas of the heart to disrupt abnormal rhythms ...